Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FHZ74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,312
Award facts
- Contract value 100% obligated
- $46,312.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Stelara 45 mg/0.5 mL syringes valued at $46,312.12 with a firm fixed price structure. This non-set-aside contract represents a competitive award for a critical pharmaceutical product supporting federal medical procurement needs. The delivery order is expected to be completed by July 22, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award is issued as a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in supporting federal medical supply chains through multiple competitively awarded contracts with the Defense Logistics Agency. The company's portfolio encompasses a comprehensive range of pharmaceutical products and medical supplies serving military and veteran healthcare systems, including brand-name medications, generics, vaccines, and specialized medical devices. The underlying IDV serves as a global pharmaceutical support vehicle enabling the company to supply medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Quick answers
Who was awarded contract SPE2DB25FHZ74?
SPE2DB25FHZ74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FHZ74 worth?
The government has obligated $46,312 on SPE2DB25FHZ74.
Is contract SPE2DB25FHZ74 an order under another contract?
Yes. SPE2DB25FHZ74 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHZ74 competed?
The extent of competition for SPE2DB25FHZ74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award